Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings

Shares (Q2 2026)
549,830
Value
$14.1M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of DNLI by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026549,830$14.1M<0.1%−441,438−44.5%ReducedHolders
Q1 2026991,268$19.0M<0.1%+227,376+29.8%AddedHolders
Q4 2025763,892$12.6M<0.1%−23,137−2.9%ReducedHolders
Q3 2025787,029$11.4M<0.1%−618,221−44.0%ReducedHolders
Q2 20251,405,250$19.7M<0.1%−783,172−35.8%ReducedHolders
Q1 20252,188,422$29.8M<0.1%+399,685+22.3%AddedHolders
Q4 20241,788,737$36.5M<0.1%−178,404−9.1%ReducedHolders
Q3 20241,967,141$57.3M0.1%−451,692−18.7%ReducedHolders
Q2 20242,418,833$56.2M0.1%+272,454+12.7%AddedHolders
Q1 20242,146,379$44.0M0.1%+478,982+28.7%AddedHolders
Q4 20231,667,397$35.8M0.1%+1,667,397NewHolders
Q2 20230$00.0%−350,539−100.0%Sold outHolders
Q1 2023350,539$8.08M<0.1%−610,100−63.5%ReducedHolders
Q4 2022960,639$26.7M0.1%+284,769+42.1%AddedHolders
Q3 2022675,870$20.7M0.1%−141,780−17.3%ReducedHolders
Q2 2022817,650$24.1M0.1%+664,795+434.9%AddedHolders
Q1 2022152,855$4.92M<0.1%−231,089−60.2%ReducedHolders
Q4 2021383,944$17.1M<0.1%−147,414−27.7%ReducedHolders
Q3 2021531,358$26.8M0.1%−114,641−17.7%ReducedHolders
Q2 2021645,999$50.7M0.3%+546,481+549.1%AddedHolders
Q1 202199,518$5.68M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.